Probiotics in the development and treatment of allergic disease

Area of Science:

• Microbiology
• Immunology
• Allergology

Background:

• Gut microbiota composition differentiates allergic from healthy children, potentially before symptoms appear.
• Maternal bacterial inoculation is a key factor influencing a child's future allergy risk.
• Bifidobacterium species are identified as significant determinants of allergic disease risk.

Purpose of the Study:

• To explore the role of gut microbiota in early life allergy development.
• To investigate the potential of probiotics as an early intervention for allergic diseases.
• To assess the impact of probiotics on intestinal permeability and immune responses.

Main Methods:

• Analysis of gut microbiota composition in allergic versus healthy children.
• Evaluation of probiotic interventions for modulating microbial colonization.
• Assessment of changes in intestinal permeability and IgA responses.

Main Results:

• Gut microbiota profiles can distinguish between allergic and healthy children.
• Probiotics show potential in modulating early microbial colonization.
• Probiotics may reverse increased intestinal permeability and enhance IgA responses in allergic children.

Conclusions:

• Early gut microbial colonization, influenced by the mother, is critical for allergy development.
• Probiotics represent a promising early intervention strategy for allergic diseases.
• Probiotics can positively impact gut barrier function and immune responses, potentially alleviating allergic inflammation.